AIMD · Ainos, Inc.

Ainos, Inc. announced its financial results for the fiscal year ended December 31, 2025, highlighting a significant commercial transition driven by its AI Nose platform. The company reported revenue of $124,157, a substantial increase of approximately 499% compared to the prior year, primarily attributed to progress in AI Nose commercialization within industrial markets. A notable operational improvement was the shift to a positive gross margin of approximately 82.9%, a significant turnaround from a gross loss in 2024. Management noted that total operating expenses, excluding share-based compensation, depreciation, and amortization, decreased by 9% year-over-year, reflecting disciplined cost management, although reported operating expenses increased slightly by about 2%. Consequently, the net loss remained relatively stable at $14.77 million, a marginal improvement from the $14.86 million loss recorded in 2024. The balance sheet reflects a tight liquidity position with cash and cash equivalents of $417,353 as of December 31, 2025. However, the company strengthened its financial position post year-end with a New Taiwan Dollar 90 million financing (approximately $2.82 million). Management indicated this capital provides necessary liquidity to support ongoing operations and deployment execution. Strategically, the company is gaining momentum in semiconductor environments, with early-stage deployments underway, including a three-year, $2.1 million deployment for semiconductor packaging and testing environments targeted for completion in Q2 2026.